Arsenic Trioxide in Hematological Malignancies: The New Discovery of an Ancient Drug

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|7|6|397-405

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.7, Iss.6, 2006-12, pp. : 397-405

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Arsenic trioxide in the treatment of haematological malignancies

By Kwong Yok-Lam  

Expert Opinion on Drug Safety, Vol. 3, Iss. 6, 2004-11 ,pp. : 589-597

Informa Healthcare

Access to resources Recommend Favorite

Investigational antibody-drug conjugates for hematological malignancies

By Polson Andrew G   Ho William Y   Ramakrishnan Vanitha  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 1, 2011-01 ,pp. : 75-85

Informa Healthcare

Access to resources Recommend Favorite

Editorial [Hot topic: New and Emerging Drug Targets for the Treatment of Hematological Malignancies (Guest Editors: Dr. Linda J. Bendall)]

By  

Current Drug Targets, Vol. 11, Iss. 7, 2010-07 ,pp. : 767-768

Bentham Science Publishers

Access to resources Recommend Favorite

Proteasome Inhibition as a New Therapeutic Principle in Hematological Malignancies

By  

Current Drug Targets, Vol. 7, Iss. 10, 2006-10 ,pp. : 1341-1347

Bentham Science Publishers

Access to resources Recommend Favorite

New nucleoside analogs for patients with hematological malignancies

By Robak Tadeusz  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 3, 2011-03 ,pp. : 343-359

Informa Healthcare

Access to resources Recommend Favorite